Related Experiment Videos
Apoptosis and systemic lupus erythematosus
Ahmed Sheriff1, Udo S Gaipl, Reinhard E Voll
1Institute for Clinical Immunology and Rheumatology, Medical Department III, University of Erlangen-Nüremberg, Glueckstrasse 4a, 91054 Erlangen, Germany.
Rheumatic Diseases Clinics of North America
|July 21, 2004
Summary
Failure to clear dying cells, particularly nuclear material, can lead to autoimmune diseases like lupus. This process involves dendritic cells presenting autoantigens, activating T cells and subsequently B cells to produce autoantibodies.
Area of Science:
- Immunology
- Cell Biology
- Pathogenesis of Autoimmune Diseases
Background:
- Impaired clearance of apoptotic cells leads to accumulation of cellular debris.
- This debris can be processed by antigen-presenting cells, potentially triggering autoimmune responses.
- Defects in apoptotic cell clearance are implicated in systemic lupus erythematosus (SLE).
Purpose of the Study:
- To elucidate the mechanisms by which impaired apoptotic cell clearance contributes to autoimmunity.
- To investigate the role of dendritic cells and follicular dendritic cells in autoantigen presentation.
- To understand the activation pathways of autoreactive B cells and T cells.
Main Methods:
- The study proposes a mechanistic pathway based on existing literature and immunological principles.
- It integrates knowledge of apoptotic cell clearance, antigen presentation, and lymphocyte activation.
- No new experimental data is presented; it's a conceptual review.
Main Results:
- Accumulation of apoptotic debris, especially nuclear material, due to impaired clearance.
- Uptake and presentation of autoantigens by dendritic cells (DCs) to naive T cells.
- Activation of autoreactive T helper cells and B cells, leading to autoantibody production.
Conclusions:
- Failure of apoptotic cell clearance is a central mechanism in the pathogenesis of autoimmune diseases like SLE.
- The process involves sequential steps from cellular debris accumulation to autoantibody production.
- Targeting defects in apoptotic cell clearance may offer therapeutic strategies for autoimmune conditions.